![](https://investorshub.advfn.com/uicon/19649.png?cb=1607617291)
Friday, September 04, 2020 8:44:59 AM
The biotech company Relief Therapeutics has appointed Gilles Della Corte as medical director with immediate effect, the Geneva-based company announced on Friday.
Dr. Della Corte, a cardiologist, has more than 30 years of experience in the biotechnology sector.
Relief Therapeutics announced on Friday the appointment of Gilles Della Corte, M.D., as medical director, with immediate effect.
Dr. Della Corte, a cardiologist, has more than 30 years of experience in the biotechnology sector, including at Merck Serono, where he was responsible for development, from proof of concept to project lifecycle management in several pathological areas, including cardiology, rheumatology, oncology and endocrinology.
Earlier in his career, he also held positions of (cont'd)
https://www.agefi.com/home/entreprises/detail/edition/online/article/la-societe-biotechnologique-relief-therapeutics-a-nomme-avec-effet-immediat-gilles-della-corte-au-poste-de-directeur-medical-a-annonce-vendredi-lentreprise-genevoise-498663.html
~ Money Making Money ~
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM